Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Erika Hamaguchi"'
Autor:
Akinori Hara, Miho Shimizu, Erika Hamaguchi, Hirokazu Kakuda, Kenzo Ikeda, Toshiya Okumura, Kiyoki Kitagawa, Yoshitaka Koshino, Motoo Kobayashi, Kazuya Takasawa, Yukimasa Hisada, Tadashi Toyama, Yasunori Iwata, Norihiko Sakai, Takashi Wada
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 3, Pp n/a-n/a (2020)
Summary Aims We assessed the potential efficacy and safety of propagermanium (PG), an organic compound that inhibits the C–C chemokine receptor type 2, administration in patients with type 2 diabetes and nephropathy. Furthermore, we assessed the fe
Externí odkaz:
https://doaj.org/article/e80ee15214754680a4bcc0ec00aa9d86
We searched for massive galaxy population in the known large-scale high-density structure of Lyman$~α$ emitters (LAEs) at $z=2.39$ near the radio galaxy 53W002 by using $B,~V,~i^\prime,~J,~H,~{\rm{and}}~K_s$-bands imaging data taken with Suprime-Cam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92d9bbbb5a06ea3dc83f3da6765f8b4
http://arxiv.org/abs/2109.02019
http://arxiv.org/abs/2109.02019
Autor:
Yasunori Iwata, Erika Hamaguchi, Akinori Hara, Koshino Y, Kazuya Takasawa, Ikeda K, Yukimasa Hisada, Miho Shimizu, Hirokazu Kakuda, Tadashi Toyama, Kiyoki Kitagawa, Motoo Kobayashi, Toshiya Okumura, Takashi Wada, Norihiko Sakai
Publikováno v:
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 3, Pp n/a-n/a (2020)
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 3, Pp n/a-n/a (2020)
Summary Aims We assessed the potential efficacy and safety of propagermanium (PG), an organic compound that inhibits the C–C chemokine receptor type 2, administration in patients with type 2 diabetes and nephropathy. Furthermore, we assessed the fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24da1131e7b8f747390f9008a00e2e2
https://pubmed.ncbi.nlm.nih.gov/32704573
https://pubmed.ncbi.nlm.nih.gov/32704573
Autor:
Akie Nakamura, Keisuke Nagasaki, Masayo Kagami, Yasuyuki Nishimura, Tsutomu Ogata, Yoichi Matsubara, Reiko Horikawa, Shinichiro Sano, Akihiro Umezawa, Keiko Matsubara, Kohji Okamura, Maki Fukami, Toshihiro Tajima, Erika Hamaguchi
Publikováno v:
The Journal of clinical endocrinology and metabolism. 101(7)
Pseudohypoparathyroidism type 1b (PHP-1b) results from methylation defects at the G protein stimulatory α subunit (GNAS) exon A/B-differentially methylated region (DMR). Although microduplications in the GNAS region were recently identified in two P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57675c1aaeee43a4da30aae59831101b
https://pubmed.ncbi.nlm.nih.gov/27253667
https://pubmed.ncbi.nlm.nih.gov/27253667
Autor:
Tsuguhito Ota, Akiko Shimizu, Masaru Sakurai, Erika Hamaguchi, Yumie Takeshita, Shuichi Kaneko, Toshinari Takamura
Publikováno v:
Metabolism: Clinical and Experimental. 55(11):1464-1472
金沢大学大学院医学系研究科環境社会医学
Plasminogen activator inhibitor 1 (PAI-1) is an important mediator of atherosclerosis and liver fibrosis in insulin resistance. Circulating levels of PAI-1 are elevated in obese individua
Plasminogen activator inhibitor 1 (PAI-1) is an important mediator of atherosclerosis and liver fibrosis in insulin resistance. Circulating levels of PAI-1 are elevated in obese individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3300078c7f7984e06a364ea2656da132
http://hdl.handle.net/2297/2870
http://hdl.handle.net/2297/2870
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 307:987-994
Plasminogen activator inhibitor type 1 (PAI-1) plays a role in the development of atherosclerosis in diabetic patients. PAI-1 is produced by endothelial cells stimulated with various inflammatory cytokines, such as tumor necrosis factor (TNF)-alpha,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e0cb5ee578fd62910ce051b24d4644
https://doi.org/10.1124/jpet.103.054346
https://doi.org/10.1124/jpet.103.054346
Autor:
Eishiro Mizukoshi, Kuniaki Arai, Erika Hamaguchi, Yumie Takeshita, Seiichiro Kurita, Yasuni Nakanuma, Motoko Sasaki, Tatsuya Yamashita, Yoh Zen, Shuichi Kaneko, Toshinari Takamura, Masaru Sakurai
Publikováno v:
Diabetes Care. 33:284-286
OBJECTIVE The goal of this study was to examine whether metabolic abnormalities are responsible for the histological changes observed in Japanese patients with nonalcoholic fatty liver disease (NAFLD) who have undergone serial liver biopsies. RESEARC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ae897b61dd2f9d0ee47cfcb34de5e18
https://doi.org/10.2337/dc09-0148
https://doi.org/10.2337/dc09-0148
Autor:
Hiroshi Akahori, Erika Hamaguchi, Toshinari Takamura, Takehiro Kanamori, Akiko Shimizu, Yasuyuki Nishimura, Yukiko Matsushima, Yumie Takeshita, Ken-ichiro Kato, Shuichi Kaneko, Yuki Kita, Toshiki Otoda, Hitomi Toyama-Wakakuri
Publikováno v:
BMJ Open Diabetes Research & Care
Purpose A step-up strategy for diet therapy and/or single oral antihyperglycemic agent (OHA) regimens has not yet been established. The aim of this study was to evaluate hemoglobin A1c (HbA1c) as a primary end point, and the pleiotropic effects on me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb2c0a299fa9ae7e88eb002e51538ca
https://doi.org/10.1136/bmjdrc-2015-000190
https://doi.org/10.1136/bmjdrc-2015-000190
Autor:
Erika, Hamaguchi, Toshinari, Takamura, Masaru, Sakurai, Eishiro, Mizukoshi, Yoh, Zen, Yumie, Takeshita, Seiichiro, Kurita, Kuniaki, Arai, Tatsuya, Yamashita, Motoko, Sasaki, Yasuni, Nakanuma, Shuichi, Kaneko
Publikováno v:
Diabetes Care
OBJECTIVE The goal of this study was to examine whether metabolic abnormalities are responsible for the histological changes observed in Japanese patients with nonalcoholic fatty liver disease (NAFLD) who have undergone serial liver biopsies. RESEARC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70bd8f1375fba3981930f655ae7e62e0
https://pubmed.ncbi.nlm.nih.gov/19880582
https://pubmed.ncbi.nlm.nih.gov/19880582
Autor:
Yumie Takeshita, Shuichi Kaneko, Naoto Matsuzawa-Nagata, Toshinari Takamura, Erika Hamaguchi, Hitoshi Ando, Akiko Takazakura
Publikováno v:
European journal of pharmacology. 579(1-3)
Tumor necrosis factor (TNF)-alpha and local activation of the renin-angiotensin system may contribute to insulin resistance and atherosclerosis. In this study, we investigated the involvement of these mediators in the liver. We found that the gene ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb792344320f06e6faaec72b297ee3bd
https://pubmed.ncbi.nlm.nih.gov/18078928
https://pubmed.ncbi.nlm.nih.gov/18078928